Agilent, Sera Prognostics Team on Proteomic Assays
February 12, 2013
Agilent, Sera Prognostics Team on Proteomic Assays
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Proteome Sciences, Buck Institute Partner on Test for Breast Cancer Treatment Response
July 14, 2011 / GenomeWeb Daily News - Matrix-Bio Licenses Metabolomic Biomarkers to Quest for Breast Cancer Test Development
April 11, 2013 / GenomeWeb Daily News - Sera Prognostics' 4,000-Patient Validation Study Another Sign of High-Throughput Mass Spec's Arrival
March 1, 2013 / ProteoMonitor - Children's National Medical Center Researcher Developing Proteomic Assay for Summit's DMD Drug
February 6, 2013 / GenomeWeb Daily News - Thermo Fisher, Immundiagnostik to Co-develop Mass Spec-based Assays
October 16, 2012 / GenomeWeb Daily News